MedicarePartD.guide

A non-government resource built from CMS public data

Ustekinumab-Aekn on Horizon Medicare Blue Rx Enhanced (S5993-003)

Covered, with prior authorization required.

Tier 4 (non-preferred drug). Quantity limit of 1.5 per 84 days.

$1,017.78
Patient pays / month, after deductible
$1,127.78
Patient pays / month, before the $200.00 deductible
$3,053.35
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

USTEKINUMAB-AEKN 45 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $2,261.74 for a month. Other covered strengths are listed below.

Prior authRequired on all 2 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 2 covered strengths and forms
FormTierPatient pays / monthLimits
USTEKINUMAB-AEKN 45 mg/.5mL Injection, Solution4$1,017.78PA · 1.5 per 84 days
USTEKINUMAB-AEKN 90 mg/mL Injection, Solution5$1,256.53PA · 3 per 84 days

Verify with the plan before prescribing or filling. Member services: (800)391-1906. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5993-003